PACLITAX NAB 100MG ING

About

Nab-paclitaxel (Paclitax Nab) is an innovative, albumin-bound nanoparticle formulation of paclitaxel, a potent microtubule inhibitor used in the treatment of various solid tumors. This unique formulation allows for higher doses of paclitaxel to be delivered to cancer cells with a reduced incidence of solvent-related toxicities, such as hypersensitivity reactions, which are common with conventional paclitaxel. Nab-paclitaxel works by disrupting the normal function of microtubules, essential components for cell division, leading to cell cycle arrest and programmed cell death in rapidly proliferating cancer cells. The albumin binding facilitates enhanced tumor penetration and accumulation, making it an effective option for patients with metastatic breast cancer, non-small cell lung cancer, and pancreatic adenocarcinoma.

Uses

• Metastatic breast cancer
• Non-small cell lung cancer
• Metastatic pancreatic adenocarcinoma
• Advanced gastric cancer (off-label)

Directions For Use

Administered intravenously by a healthcare professional, typically as an infusion over 30 minutes.

Benefits

• Reduced incidence of hypersensitivity reactions
• Higher drug delivery to tumor sites
• Effective in various solid tumors
• Can be used in combination therapies
• Improved safety profile over conventional paclitaxel
• No need for premedication with corticosteroids

Side Effects

• Myelosuppression (neutropenia)
• Peripheral neuropathy
• Fatigue
• Alopecia (hair loss)
• Nausea
• Diarrhea
• Arthralgia (joint pain)
• Myalgia (muscle pain)
• Rash
• Infection
• Liver enzyme elevation
• Edema
• Mucositis

Safety Measures

• Alcohol - Avoid alcohol during treatment as it can exacerbate side effects like nausea, fatigue, and potential liver toxicity.
• Pregnancy - Contraindicated due to potential for severe fetal harm. Effective contraception is required for both male and female patients during and after treatment.
• Breastfeeding - Not recommended due to potential for serious adverse reactions in breastfed infants. Discontinue breastfeeding during treatment.
• Liver - Use with caution in patients with pre-existing liver impairment; dose adjustments may be necessary based on liver function tests.
• Kidney - Use with caution in patients with renal impairment; monitor renal function closely as dose adjustments may be considered.
• Lung - Use with caution in patients with pre-existing pulmonary conditions due to rare reports of pneumonitis.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.